PARTNERING
Partnering with Profectus

Profectus actively seeks to apply the PBS Vax™ platform in collaboration with pharmaceutical and biotechnology partners to:
  • create innovative new vaccines for infectious diseases
  • improve the performance of existing and pipeline vaccines by enabling them to achieve greater immunogenicity
  • develop transformational oncolytic vaccines for cancer

  • For more information, please contact:
    Jeffrey Meshulam
    President
    443-743-1107
    meshulam@profectusbiosciences.net
© 2017 Profectus BioSciences, Inc. All Rights Reserved.  |  User Login